Heidelberg Pharma AG
Clinical trials sponsored by Heidelberg Pharma AG, explained in plain language.
Heidelberg Pharma AG
HPHA
FRA
Biopharmaceutical company developing antibody-drug conjugates for cancer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.